Liberum Capital reaffirmed their buy rating on shares of Charles Taylor PLC (LON:CTR) in a report released on Monday. Liberum Capital currently has a GBX 327 ($4.34) target price on the stock.

Other equities research analysts have also recently issued research reports about the company. Peel Hunt reiterated an add rating and set a GBX 290 ($3.85) target price on shares of Charles Taylor PLC in a report on Thursday, August 10th. Numis Securities Ltd cut Charles Taylor PLC to an add rating and set a GBX 312 ($4.15) target price on the stock. in a report on Wednesday, October 4th.

Charles Taylor PLC (CTR) opened at 278.6101 on Monday. The stock’s market cap is GBX 189.51 million. Charles Taylor PLC has a 12 month low of GBX 201.00 and a 12 month high of GBX 306.00. The company’s 50-day moving average price is GBX 266.75 and its 200-day moving average price is GBX 242.60.

WARNING: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at

The business also recently announced a dividend, which will be paid on Friday, November 10th. Shareholders of record on Thursday, October 12th will be issued a dividend of GBX 3.31 ($0.04) per share. This represents a yield of 1.29%. The ex-dividend date is Thursday, October 12th.

Charles Taylor PLC Company Profile

Charles Taylor plc is a United Kingdom-based provider of professional services to the insurance market. The Company operates through four segments: management services business, adjusting services business, insurance support services business and owned insurance companies business. The management services business segment provides mutual management service.

Receive News & Ratings for Charles Taylor PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles Taylor PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.